Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up COVID-19: Information for Patients and Caregivers We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.What you need to know 1669 News Items found Clinical Trial for Beta-Thalassemia Brings Important Insights for Treating Blood Disorders with Stem Cell Gene Therapy Thursday, January 6, 2022 A gene therapy approach could prove effective at treating an inherited blood disorder called beta (β)-thalassemia. Feature How a Mishap in Early Development Can Lead to a Lifetime of Cancer Risk Wednesday, January 5, 2022 MSK researchers have found mutations that arise in embryos can convey a risk of cancer that’s similar to what’s seen in people with inherited cancer mutations. New Research Shows the HPV Cancer Vaccine Saves Lives Monday, January 3, 2022 Learn why MSK recommends that children be vaccinated against HPV. From Breaks to Breakthroughs Saturday, January 1, 2022 Maria Jasin’s discoveries have led to concrete advances in patient care. The targeted medicines called PARP inhibitors, for example, are based on knowledge gained from her work. Looking for Patterns in Cancer Survivors Saturday, January 1, 2022 Cancer treatment is complex. For every type of cancer, there is a range of treatments, side effects, and outcomes. Machine learning can help make sense of these variables, according to Quaid Morris. Sloan Kettering Institute Scientists Retool CAR T Cells to Serve as ‘Micropharmacies’ for Cancer Drugs Thursday, December 30, 2021 These souped-up versions may help overcome some limitations of existing CAR T cells. Memorial Sloan Kettering and the Chinese Thoracic Oncology Group Discuss Opportunities for Further Collaboration to Accelerate International Clinical Trials During Annual Symposium Monday, December 27, 2021 Building on their long-term shared commitment to international collaboration on cancer research and care – Memorial Sloan Kettering Cancer Center (MSK)... 2021 in Review: 10 Important Clinical Advances in Cancer at MSK Wednesday, December 22, 2021 Learn about some of the most important clinical advances made at MSK in 2021. 6 Tips to Improve Your Immunity Wednesday, December 22, 2021 Learn how to keep your immune system balanced. Feature How Does COVID-19 Affect People with Blood Cancer? MSK Researchers Investigate Tuesday, December 21, 2021 MSK researchers have led much of the research looking at how people with blood cancers respond to COVID-19 infections and vaccines. In the News MSK and the Abyssinian Baptist Church Share Ways to Stay Healthy This Holiday Season Tuesday, December 21, 2021 In this online discussion, panelists give tips for managing both your physical and mental well-being during the holiday season, especially against the backdrop of the ongoing pandemic. Sloan Kettering Institute Year in Review: 10 Noteworthy Science Breakthroughs of 2021 Tuesday, December 21, 2021 Take a look back at some of the biggest science stories from this past year. A Conversation with MSK’s Charles Sawyers: What’s Next for Precision Oncology Friday, December 17, 2021 Twenty years ago, Charles Sawyers played a pivotal role in the development of Gleevec, a game-changing cancer drug that has gone on to save millions of lives and open doors for research and innovation. In this episode, Dr. Diane Reidy-Lagunes talks with Dr. Sawyers about what’s next in the field of cancer pharmaceuticals. Is another silver bullet on the horizon? Chief Operating Officer Kathryn Martin Receives Distinguished Leadership Honor Wednesday, December 15, 2021 Kathryn was honored with The Leon J. Warshaw Leadership in Healthcare Award. Finding How Telemedicine Reshaped Genetic Counseling during the COVID-19 Pandemic Wednesday, December 15, 2021 A recent study from MSK investigators found that most patients who received genetic counseling by telemedicine during the early months of the pandemic reported being highly satisfied with the care they received. Finding Drug Combination Improves Outcomes for Common Type of Lymphoma Tuesday, December 14, 2021 An international phase 3 trial has found that polatuzumab vedotin improves outcomes for patients with newly diagnosed diffuse large B cell lymphoma. Updates from SABCS 2021: Personalizing Diet and Exercise Plans for Breast Cancer, Zapping Metastatic Cells, Making Targeted Drugs Work Better Thursday, December 9, 2021 MSK physicians and researchers discussed the latest trends in breast cancer research at the annual meeting held in San Antonio. Coping with Cancer at the Holidays: 7 Tips from Someone Who Has Been There Wednesday, December 8, 2021 Find ways to cope with cancer during the holiday season. Clinical Microbiologist Esther Babady Recognized on Crain’s New York Business 2021 Empire Whole Health Heroes List Monday, December 6, 2021 Throughout the pandemic, Dr. Babady used her vast expertise in clinical microbiology and molecular diagnosis of infectious diseases to keep employees and patients safe. MSK Joins the American Cancer Society Cancer Action Network for Policy Forum on Health Equity Thursday, December 2, 2021 MSK’s Francesca Gany emphasized the need to overcome the digital and linguistic divides between the healthcare system and communities. 14 15 16 17 18 19 20 21 22 Book traversal links for Newsroom Previous Newsroom Next MSK Experts Present Research at Bone Marrow Transplant and Cellular Therapy Meeting